Nā huahana a me nā mea ho'onā a Macro & Micro-Test

ʻO ka PCR Fluorescence |Hoʻonui Isothermal |Colloidal Gold Chromatography |Fluorescence Immunochromatography

Nā huahana

  • Plasmodium Nucleic Acid

    Plasmodium Nucleic Acid

    Hoʻohana ʻia kēia kit no ka ʻike in vitro qualitative o ka malaria parasite nucleic acid i nā laʻana koko peripheral o nā maʻi i manaʻo ʻia he maʻi plasmodium.

  • ʻO Trichomonas Vaginalis Nucleic Acid

    ʻO Trichomonas Vaginalis Nucleic Acid

    Hoʻohana ʻia kēia kit no ka ʻike qualitative o Trichomonas vaginalis nucleic acid i loko o nā laʻana huna huna urogenital kanaka.

  • ʻO Candida Albicans Nucleic Acid

    ʻO Candida Albicans Nucleic Acid

    Kuhi ʻia kēia pahu no ka ʻike in vitro o Candida Albicans nucleic acid i loko o ka hoʻohemo ʻana a me nā laʻana sputum.

     

  • ʻO Candida Albicans Nucleic Acid

    ʻO Candida Albicans Nucleic Acid

    Kuhi ʻia kēia pahu no ka ʻike in vitro qualitative o ka nucleic acid o Candida tropicalis i loko o nā ʻāpana genitourinary a i ʻole nā ​​​​mea hoʻohālike sputum clinical.

  • Influenza A/B Antigen

    Influenza A/B Antigen

    Hoʻohana ʻia kēia kime no ka ʻike ʻana i ka maʻi influenza A a me B antigens i ka oropharyngeal swab a me ka nasopharyngeal swab samples.

  • ʻO ka Middle East Respiratory Syndrome Coronavirus Nucleic Acid

    ʻO ka Middle East Respiratory Syndrome Coronavirus Nucleic Acid

    Hoʻohana ʻia ka pahu no ka ʻike qualitative o MERS coronavirus nucleic acid i loko o nā swabs nasopharyngeal me ka Middle East Respiratory Syndrome (MERS) coronavirus.

  • Hoʻohui ʻia nā mea maʻi hanu

    Hoʻohui ʻia nā mea maʻi hanu

    Hoʻohana ʻia kēia pahu no ka ʻike qualitative o nā pathogens hanu i loko o ka waikawa nucleic i unuhi ʻia mai nā laʻana oropharyngeal swab kanaka.ʻO nā maʻi maʻi i ʻike ʻia: ka maʻi influenza A (H1N1, H3N2, H5N1, H7N9), ka maʻi influenza B (Yamataga, Victoria), ka maʻi parainfluenza (PIV1, PIV2, PIV3), metapneumovirus (A, B), adenovirus (1, 2, 3). , 4, 5, 7, 55), respiratory syncytial (A, B) a me ka maʻi ʻala.

  • Mycoplasma Pneumoniae Nucleic Acid

    Mycoplasma Pneumoniae Nucleic Acid

    Hoʻolālā ʻia kēia pahu no ka ʻike in vitro qualitative o Mycoplasma pneumoniae (MP) nucleic acid i loko o nā swabs puʻu kanaka.

  • ʻAka Nucleic Acid Respiratory Human Respiratory Syncytial Virus

    ʻAka Nucleic Acid Respiratory Human Respiratory Syncytial Virus

    Hoʻohana ʻia kēia pahu no ka ʻike in vitro qualitative o Human respiratory syncytial virus (HRSV) nucleic acid i loko o nā laʻana swab puʻu.

  • 14 Nā ʻano o ka HPV Nucleic Acid Type

    14 Nā ʻano o ka HPV Nucleic Acid Type

    ʻO ka Human Papillomavirus (HPV) no ka ʻohana Papillomaviridae o kahi maʻi molelaʻi liʻiliʻi, ʻaʻole i hoʻopuni ʻia, pōʻaiapuni ʻelua mau kaula DNA, me ka lōʻihi o ka genome ma kahi o 8000 mau kumu kumu (bp).Hoʻopili ka HPV i ke kanaka ma o ka hoʻopili pololei ʻana a i ʻole ka hoʻopili ʻana me nā mea haumia a i ʻole ka hoʻouna ʻana i ka moekolohe.ʻAʻole pili wale ka maʻi maʻi, akā hiki ke hoʻopili wale i ka ʻili kanaka a me ka mucosal epithelial cell, e hoʻoulu ai i nā ʻano papillomas a i ʻole warts i ka ʻili kanaka a me ka pōʻino proliferative i ka epithelium tract reproductive.

     

    He kūpono ke kit no ka ʻike ʻana i ke ʻano in vitro qualitative type o nā ʻano papillomaviruses 14 (HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68) nucleic acids i loko. nā laʻana mimi kanaka, nā laʻana o ka puʻu ʻāʻī o ka ʻōpū wahine, a me nā laʻana o ka puʻu wahine.Hiki iā ia ke hāʻawi wale i nā mea kōkua no ka ʻike a me ka mālama ʻana i ka maʻi HPV.

  • ʻO ka maʻi maʻi maʻi maʻi maʻi nucleic acid

    ʻO ka maʻi maʻi maʻi maʻi maʻi nucleic acid

    ʻO kēia pahu i manaʻo ʻia no ka ʻike in vitro qualitative o Influenza B virus nucleic acid ma nā laʻana o ka nasopharyngeal a me ka oropharyngeal swab.

  • Influenza A Virus Nucleic Acid

    Influenza A Virus Nucleic Acid

    Hoʻohana ʻia ka pahu no ka ʻike ʻana i ka waika nucleic virus influenza A i loko o nā swabs pharyngeal kanaka in vitro.